TransMedics Group, Inc. (TMDX)
86.38
-7.64
(-8.13%)
USD |
NASDAQ |
Nov 20, 10:46
TransMedics Group Cash from Operations (Quarterly) : 36.00M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 36.00M |
| June 30, 2026 | 17.31M |
| March 31, 2026 | 24.53M |
| December 31, 2025 | 34.51M |
| September 30, 2025 | 69.57M |
| June 30, 2025 | 91.61M |
| March 31, 2025 | -2.855M |
| December 31, 2024 | 19.66M |
| September 30, 2024 | 6.857M |
| June 30, 2024 | 25.72M |
| March 31, 2024 | -3.435M |
| December 31, 2023 | 8.304M |
| September 30, 2023 | -6.868M |
| June 30, 2023 | -5.803M |
| March 31, 2023 | -8.661M |
| December 31, 2022 | -4.035M |
| September 30, 2022 | -14.28M |
| June 30, 2022 | -9.094M |
| March 31, 2022 | -18.41M |
| Date | Value |
|---|---|
| December 31, 2021 | -6.648M |
| September 30, 2021 | -9.35M |
| June 30, 2021 | -5.536M |
| March 31, 2021 | -7.33M |
| December 31, 2020 | -7.138M |
| September 30, 2020 | -6.412M |
| June 30, 2020 | -8.539M |
| March 31, 2020 | -8.176M |
| December 31, 2019 | -7.264M |
| September 30, 2019 | -5.597M |
| June 30, 2019 | -12.16M |
| March 31, 2019 | -7.266M |
| December 31, 2018 | -39.50M |
| September 30, 2018 | -6.125M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -5.285M |
| September 30, 2017 | -4.996M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Boston Scientific Corp. | 1.048B |
| Insulet Corp. | 123.40M |
| Abbott Laboratories | 1.737B |
| Baxter International, Inc. | 558.00M |
| Becton, Dickinson & Co. | 1.458B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -13.71M |
| Cash from Financing (Quarterly) | -1.915M |
| Free Cash Flow | 44.70M |
| Free Cash Flow Per Share (Quarterly) | 0.676 |
| Free Cash Flow to Equity (Quarterly) | 28.42M |
| Free Cash Flow to Firm (Quarterly) | 32.75M |
| Free Cash Flow Yield | 1.49% |